September 9, 2020 Comments Off on Patent delisted for Acorda drug AMPYRA Posted in: Uncategorized
Annual Drug Patent Expirations for AMPYRA Ampyra is a drug marketed by Acorda and is included in one NDA. It is available from two suppliers. Drug patent litigation for AMPYRA.…
The post Patent delisted for Acorda drug AMPYRA appeared first on DrugPate…
September 9, 2020 Comments Off on Patent delisted for Boehringer Ingelheim drug JARDIANCE Posted in: Uncategorized
Annual Drug Patent Expirations for JARDIANCE Jardiance is a drug marketed by Boehringer Ingelheim and is included in one NDA. It is available from four suppliers. There are six patents…
The post Patent delisted for Boehringer Ingelheim drug JARDIANCE a…
